Veeva Systems Inc.

What they do

Veeva sells cloud software, data, and business consulting to pharmaceutical, biotech, and MedTech companies, spanning R&D through commercialization. Its offerings are grouped into Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud, all built on the Veeva Vault platform. Revenue comes from subscription fees for software/data access and professional services for implementation, configuration, and managed services. Veeva also offers certain R&D and Quality solutions to non-life-sciences industries in North America and Europe.

Revenue drivers

• R&D and Quality Solutions — Includes Veeva Development Cloud and Veeva Quality Cloud; generated 53% of subscription and 55% of total revenues in fiscal 2026, with management expecting this share to grow.
• Commercial Solutions — Includes Veeva Commercial Cloud and Veeva Data Cloud; generated 47% of subscription and 45% of total revenues in fiscal 2026.
• Subscription revenues — Core recurring cloud and data fees; $2.684 billion in fiscal 2026, 84% of total revenues, growing 17% year over year.
• Professional services and other — Includes implementation services, configuration, managed services, speakers bureau logistics, and Veeva Business Consulting; 16% of fiscal 2026 total revenues.

Recent performance

For the first quarter ended April 30, 2026, total revenues rose 16% year over year to $882.9 million, with subscription revenues up 15% to $730.2 million. Net income was $260.9 million, up 14% year over year, and fully diluted EPS was $1.57, compared to $1.37 a year ago. Operating income was $273.1 million, up 17%. Fiscal 2026 full-year results showed total revenues of $3.20 billion and net income of $908.9 million, both up 16% and 27% respectively from the prior year. Customer count reached 1,552 as of January 31, 2026, up from 1,477 a year earlier.

Strategy

Management is shifting from an industry-specific application company to an industry-specific application and AI agent company. Priorities include expanding Veeva AI, with Vault AI planned to expand to all Vault applications in August and Veeva Falcon, an agentic labor platform, planned for early adopter release in November. The company is deepening its R&D and Quality Solutions, which are expected to grow as a percentage of revenue. Commercial focus includes growing Vault CRM adoption, adding 27 new customers in the quarter and surpassing 150 live. Veeva also plans to offer certain R&D and Quality solutions to industries outside life sciences, mainly in North America and Europe.

Risks

• Security breaches — A security breach or unauthorized access to customer data could make solutions appear insecure, reduce usage, and create significant liabilities.
• Intense competition in CRM — Competition is particularly intense in the CRM market as Veeva transitions customers from its legacy CRM application to Vault CRM, and failure to compete effectively could lead to customer losses.
• Solution defects or disruptions — Defects or service disruptions could diminish demand and reduce revenues, while also exposing Veeva to substantial liability.
• Customer concentration — Revenues are relatively concentrated among a small number of key customers; losing one or more could cause revenues to decline.
• Life sciences industry dependence — Nearly all revenues come from life sciences customers, so adverse industry factors such as regulatory changes or drug pricing reforms could hurt results.

Outlook

For the fiscal second quarter ending July 31, 2026, management guides total revenues between $902 and $905 million. For fiscal year ending January 31, 2027, they expect total revenues between $3,635 and $3,645 million, non-GAAP operating income of about $1,610 million, and non-GAAP fully diluted EPS of approximately $9.05. Management says first quarter results exceeded guidance and that they are raising full-year guidance.